SG11202101945PA - Peptide therapeutics for the treatment of cancer and uses thereof - Google Patents
Peptide therapeutics for the treatment of cancer and uses thereofInfo
- Publication number
- SG11202101945PA SG11202101945PA SG11202101945PA SG11202101945PA SG11202101945PA SG 11202101945P A SG11202101945P A SG 11202101945PA SG 11202101945P A SG11202101945P A SG 11202101945PA SG 11202101945P A SG11202101945P A SG 11202101945PA SG 11202101945P A SG11202101945P A SG 11202101945PA
- Authority
- SG
- Singapore
- Prior art keywords
- cancer
- treatment
- peptide therapeutics
- therapeutics
- peptide
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- A61K38/1761—Apoptosis related proteins, e.g. Apoptotic protease-activating factor-1 (APAF-1), Bax, Bax-inhibitory protein(s)(BI; bax-I), Myeloid cell leukemia associated protein (MCL-1), Inhibitor of apoptosis [IAP] or Bcl-2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4747—Apoptosis related proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/30—Non-immunoglobulin-derived peptide or protein having an immunoglobulin constant or Fc region, or a fragment thereof, attached thereto
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Toxicology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Hematology (AREA)
- Oncology (AREA)
- Marine Sciences & Fisheries (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201862723428P | 2018-08-27 | 2018-08-27 | |
PCT/US2019/048414 WO2020046997A1 (en) | 2018-08-27 | 2019-08-27 | Peptide therapeutics for the treatment of cancer and uses thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
SG11202101945PA true SG11202101945PA (en) | 2021-03-30 |
Family
ID=69643321
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG11202101945PA SG11202101945PA (en) | 2018-08-27 | 2019-08-27 | Peptide therapeutics for the treatment of cancer and uses thereof |
Country Status (12)
Country | Link |
---|---|
US (1) | US20210361742A1 (zh) |
EP (1) | EP3844262A4 (zh) |
JP (1) | JP2021534826A (zh) |
KR (1) | KR20210097690A (zh) |
CN (1) | CN113195704A (zh) |
AU (1) | AU2019327424A1 (zh) |
BR (1) | BR112021003812A2 (zh) |
CA (1) | CA3111216A1 (zh) |
IL (1) | IL281091A (zh) |
MX (1) | MX2021002245A (zh) |
SG (1) | SG11202101945PA (zh) |
WO (1) | WO2020046997A1 (zh) |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2081954B1 (de) * | 2006-10-24 | 2012-06-13 | BASF Plant Science GmbH | Verfahren zur erhöhung der resistenz gegen biotrophe pilze in pflanzen |
-
2019
- 2019-08-27 SG SG11202101945PA patent/SG11202101945PA/en unknown
- 2019-08-27 CA CA3111216A patent/CA3111216A1/en active Pending
- 2019-08-27 JP JP2021535481A patent/JP2021534826A/ja active Pending
- 2019-08-27 US US17/272,160 patent/US20210361742A1/en active Pending
- 2019-08-27 EP EP19854677.2A patent/EP3844262A4/en active Pending
- 2019-08-27 KR KR1020217009024A patent/KR20210097690A/ko unknown
- 2019-08-27 WO PCT/US2019/048414 patent/WO2020046997A1/en unknown
- 2019-08-27 BR BR112021003812-4A patent/BR112021003812A2/pt not_active Application Discontinuation
- 2019-08-27 AU AU2019327424A patent/AU2019327424A1/en not_active Abandoned
- 2019-08-27 MX MX2021002245A patent/MX2021002245A/es unknown
- 2019-08-27 CN CN201980068839.XA patent/CN113195704A/zh active Pending
-
2021
- 2021-02-24 IL IL281091A patent/IL281091A/en unknown
Also Published As
Publication number | Publication date |
---|---|
JP2021534826A (ja) | 2021-12-16 |
MX2021002245A (es) | 2021-08-11 |
BR112021003812A2 (pt) | 2021-07-27 |
WO2020046997A1 (en) | 2020-03-05 |
IL281091A (en) | 2021-04-29 |
CN113195704A (zh) | 2021-07-30 |
AU2019327424A1 (en) | 2021-04-15 |
US20210361742A1 (en) | 2021-11-25 |
CA3111216A1 (en) | 2020-03-05 |
EP3844262A1 (en) | 2021-07-07 |
EP3844262A4 (en) | 2022-09-14 |
KR20210097690A (ko) | 2021-08-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL279347A (en) | Gremlin-1 antagonist for cancer prevention and treatment | |
FI3773689T3 (fi) | Antigeenisiä peptidejä syövän ehkäisyyn ja hoitoon | |
ZA201905851B (en) | Peptides and methods for the treatment of diabetes | |
EP3820492A4 (en) | APMV AND ITS USES IN THE TREATMENT OF CANCER | |
EP3428178A4 (en) | PEPTIDE FOR THE PREVENTION OR TREATMENT OF INFLAMMATORY DISEASES AND USE THEREOF | |
IL275525A (en) | A pharmaceutical preparation for the treatment of cancer | |
ZA202100587B (en) | Peptide compounds and therapeutic uses of same | |
GB201812647D0 (en) | Viral vectors and methods for the prevention or treatment of cancer | |
IL272147A (en) | Methods and preparations for the treatment of cancer | |
IL269121A (en) | Usl-311 for use in the treatment of cancer | |
ZA201904386B (en) | S-arrestin peptides and therapeutic uses thereof | |
ZA201901505B (en) | Phenylalanine-free protein for the treatment of pku | |
GB202005189D0 (en) | Inhibition of aminoacylase 3 (AA3) in the treatment of cancer | |
IL289371A (en) | Methylthioninium for use in the treatment of synaptopathies | |
EP3428179A4 (en) | PEPTIDE FOR THE PREVENTION OR TREATMENT OF INFLAMMATORY DISEASES AND USE THEREOF | |
IL280262A (en) | Compositions and methods for treating cancer | |
ZA202006886B (en) | R-fadrozole for use in the treatment of aldostonerism | |
IL277734A (en) | Application of short PEDF-derived peptides in the treatment of osteoarthritis | |
GB201810635D0 (en) | Peptides and cancer treatment | |
IL281091A (en) | Peptide therapy for cancer treatment and their uses | |
EP3648789C0 (en) | MTMR2-S POLYPEPTIDE FOR USE IN THE TREATMENT OF MYOPATHY | |
IL277112A (en) | Compounds for inhibiting protein degradation and methods of use thereof in the treatment of cancer | |
AU2018902173A0 (en) | Antibody-Drug-Conjugates And Uses Thereof For The Treatment Of Cancer | |
HK1251590A1 (zh) | 用於治療苯丙酮尿症(pku)的無苯丙氨酸蛋白質 | |
IL282157A (en) | Compounds and their medicinal uses |